About Kansas City Cancer Centers - South
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Radiation Therapy Oncology Group
8
SWOG Cancer Research Network
5
Alliance for Clinical Trials in Oncology
3
CTI BioPharma
1
Heron Therapeutics
1
Clinical Trials at Kansas City Cancer Centers - South
During the past decade, Kansas City Cancer Centers - South conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 15 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
2005-12-01
2022-05-20
Completed
612
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
2006-01-01
2016-12-01
Completed
1,173
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
2006-04-01
2022-12-22
Completed
1,116
APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
2006-06-01
2009-02-01
Completed
1,428
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
2006-12-01
2016-12-01
Completed
63
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
2007-05-08
2030-10-01
Active, not recruiting
788
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
2007-09-01
2017-06-01
Completed
406
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
2007-08-01
2007-12-25
Terminated
450
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kansas City Cancer Centers - South" #1 sponsor was "Radiation Therapy Oncology Group" with 8 trials, followed by "SWOG Cancer Research Network" with 5 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "CTI BioPharma" with 1 trials sponsored and "Heron Therapeutics"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Cancer Centers - South"
#1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Kansas City Cancer Centers - South
According to Clinical.Site data, the most researched conditions in "Kansas City Cancer Centers - South" are
"Prostate Cancer" (5 trials), "Lung Cancer" (3 trials), "Brain and Central Nervous System Tumors" (2 trials), "Colorectal Cancer" (2 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (2 trials). Many other conditions were trialed in "Kansas City Cancer Centers - South" in a lesser frequency.
Clinical Trials Intervention Types at Kansas City Cancer Centers - South
Most popular intervention types in "Kansas City Cancer Centers - South" are "Drug" (14 trials), "Radiation" (10 trials), "Other" (5 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (3 trials), "LHRH agonist" (2 trials), "Prednisone" (2 trials), "capecitabine" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kansas City Cancer Centers - South
The vast majority of trials in "Kansas City Cancer Centers - South" are
12 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kansas City Cancer Centers - South
Currently, there are NaN active trials in "Kansas City Cancer Centers - South".
undefined are not yet recruiting,
undefined are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Kansas City Cancer Centers - South,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kansas City Cancer Centers - South, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".